Company: ZDAN
Filing Date: 2025-02-18
Form Type: DRS/A
Source: 0001683168-25-001085
Chunk: 268

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-02-18
Form: DRS/A
Chunk 268
---
 the Underwriter’s Warrants may be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging,
short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person,
for a period of six (6) months beginning on the date of commencement of sales under this offering. In addition, although the Underwriter’s
Warrants and the underlying Ordinary Shares will be registered in the registration statement of which this prospectus forms a part, we
have also agreed that the Underwriter’s Warrants will provide for registration rights in certain cases. These registration rights
apply to all of the securities directly and indirectly issuable upon exercise of the Underwriter’s Warrants. The piggyback registration
right provided will not be greater than seven years from the effective date of the offering in compliance with FINRA Rule 5110(g)(8)(D).
The sole demand registration right provided will not be greater than five years from the commencement of sales of the public offering
in compliance with FI© Rule 5110(g)(8)(C). The warrants will have anti-dilution terms that are consistent with FINRA Rule 5110(g)(8)(E)
and (F). The Company will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other
than underwriting commissions incurred and payable by the holders.

The exercise price and number
of Ordinary Shares issuable upon exercise of the Underwriter’s Warrants may be adjusted in certain circumstances, including in
the event of a stock dividend, extraordinary cash dividend, or our recapitalization, reorganization, merger, or consolidation.

Right of First Refusal

We have granted the Underwriter
a right of first refusal (“ROFR”) to act as lead or joint investment banker, lead or joint bookrunner and/or lead or joint
placement agent, for each and every future public and private equity and debt offering which we undertake (each, a “Subject Transaction”).
The ROFR expires 24 months after the closing of this offering or the termination of the engagement letter entered into by and between
the Company and the Underwriter on February 20, 2023. The ROFR shall be contingent upon the written agreement by the Underwriter to participate
in any Subject Transaction upon the terms and conditions which should contain reasonable and customary fees for transactions of similar
size and nature; provided, however, that in no event shall the Underwriter’s fees